1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Clinical Trials Market – By Phase

1.3.2        Middle East & Africa Clinical Trials Market – By Study Design

1.3.3        Middle East & Africa Clinical Trials Market – By Indication

1.3.4        Middle East & Africa Clinical Trials Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Clinical Trials Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa PEST Analysis

4.3         Experts Opinion

5.           Middle East & Africa Clinical Trials Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Adoption and Outsourcing of Clinical Trials

5.1.2        Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry

5.2         Market Restraints

5.2.1        Expensive and Time-Consuming Process

5.3         Market Opportunities

5.3.1        Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials

5.4         Future Trends

5.4.1        AI-Driven Clinical Trials

5.5         Impact Analysis

6.           Clinical Trials Market – Middle East & Africa Analysis

6.1         Middle East & Africa Clinical Trials Market Revenue Forecast and Analysis

7.           Middle East & Africa Clinical Trials Market Revenue and Forecast To 2028 – by Study Design

7.1         Overview

7.2         Middle East & Africa Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

7.3         Interventional

7.3.1        Overview

7.3.2        Interventional: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Observational

7.4.1        Overview

7.4.2        Observational: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Expanded Access

7.5.1        Overview

7.5.2        Expanded Access: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.           Middle East & Africa Clinical Trials Market – By Phase

8.1         Overview

8.2         Middle East & Africa Clinical Trials Market, by Phase, 2022 and 2028 (%)

8.3         Phase III

8.3.1        Overview

8.3.2        Phase III: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Phase II

8.4.1        Overview

8.4.2        Phase II: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Phase IV

8.5.1        Overview

8.5.2        Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Phase I

8.6.1        Overview

8.6.2        Phase I: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Clinical Trials Market Revenue and Forecast To 2028 – Indication

9.1         Overview

9.2         Middle East & Africa Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

9.3         Autoimmune/Inflammation

9.3.1        Overview

9.3.2        Autoimmune/Inflammation: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Pain Management

9.4.1        Overview

9.4.2        Pain Management: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Oncology

9.5.1        Overview

9.5.2        Oncology: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.6         CNS Condition

9.6.1        Overview

9.6.2        CNS Condition: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Diabetes

9.7.1        Overview

9.7.2        Diabetes: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.8         Obesity

9.8.1        Overview

9.8.2        Obesity: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.9         Cardiovascular

9.9.1        Overview

9.9.2        Cardiovascular: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.10      Other

9.10.1     Overview

9.10.2     Other: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Middle East & Africa: Clinical Trials Market

10.1.1     Overview

10.1.2     Middle East & Africa: Clinical Trials Market, by Country, 2022 & 2028 (%)

10.1.2.1       Saudi Arabia: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       Saudi Arabia: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       Saudi Arabia: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.2.1.4       Saudi Arabia: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.1.5       Saudi Arabia: Clinical Trials Market, by Indication 2020-2028 (US$ Million)

10.1.2.2       UAE: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       UAE: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       UAE: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.2.2.4       UAE: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.2.5       UAE: Clinical Trials Market, by Indication 2020-2028 (US$ Million)

10.1.2.3       South Africa: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       South Africa: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       South Africa: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.2.3.4       South Africa: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.3.5       South Africa: Clinical Trials Market, by Indication 2020-2028 (US$ Million)

10.1.2.4       Rest of Middle East & Africa: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1       Overview

10.1.2.4.2       Rest of Middle East & Africa: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3       Rest of Middle East & Africa: Clinical Trials Market, by Phase, 2020–2028 (US$ Million)

10.1.2.4.4       Rest of Middle East & Africa: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.4.5       Rest of Middle East & Africa: Clinical Trials Market, by Indication 2020-2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies Done by the Companies in the Market, (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      IQVIA Holdings Inc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Parexel International Corp

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      ICON Plc

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      WuXi AppTec Co Ltd

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      SGS SA

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Syneos Health Inc

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Thermo Fisher Scientific Inc

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Laboratory Corp of America Holdings

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Saudi Arabia Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Clinical Trials Market, by Study Design– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Saudi Arabia Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 4.             UAE Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 5.             UAE Clinical Trials Market, by Study Design– Revenue and Forecast to 2028 (US$ Million)

Table 6.             UAE Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7.             South Africa Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 8.             South Africa Clinical Trials Market, by Study Design– Revenue and Forecast to 2028 (US$ Million)

Table 9.             South Africa Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Rest of Middle East & Africa Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of Middle East & Africa Clinical Trials Market, by Study Design– Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of Middle East & Africa Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Inorganic Developments Done by Companies

Table 15.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Middle East & Africa Clinical Trials Market Segmentation

Figure 2.           Middle East & Africa Clinical Trials Market, By Region

Figure 3.           Middle East & Africa Clinical Trials Market Overview

Figure 4.           Phase III Segment Held Largest Share of Phase Segment in Middle East & Africa Clinical Trials Market

Figure 5.           The UAE is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Middle East and Africa: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis

Figure 9.           Middle East & Africa Clinical Trials Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Middle East & Africa Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

Figure 11.        Interventional: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Observational: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Expanded Access: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Middle East & Africa Clinical Trials Market, by Phase 2022 and 2028 (%)

Figure 15.        Phase III: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Phase II: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Phase I: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Middle East & Africa Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

Figure 20.        Autoimmune/Inflammation: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Pain Management: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Oncology: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        CNS Condition: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Diabetes: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Obesity: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cardiovascular: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Middle East & Africa: Clinical Trials Market, by Key Country – Revenue (2022) (US$ Million)

Figure 29.        Middle East & Africa: Clinical Trials Market, by Country, 2022 & 2028 (%)

Figure 30.        Saudi Arabia: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        UAE: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        South Africa: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Rest of Middle East & Africa: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Growth Strategies Done by the Companies in the Market, (%)